Feed JNJ
JN

Johnson & Johnson JNJ · NYSE

$253.96 -0.63% (-$1.60)

Market cap
$612.0B
Enterprise value
$640.6B
P/E
38.0x
Forward P/E
21.8x
PEG
0.3x
P/S
6.2x
P/FCF
32.7x
EV/EBITDA
20.8x
ROIC
14.7%
Gross margin
71.3%
Net margin
16.2%
Dividend yield
2.08%
Payout ratio
79.1%
Net debt/EBITDA
0.9x
Beta
0.24
Free float
99.8%

About the company

Johnson & Johnson (JNJ) is a global pharmaceutical, medical, and consumer goods manufacturing company with a diverse portfolio of products. For over 130 years, they have been delivering innovative medicines, medical devices, and consumer products that improve people's lives worldwide. With a strong market position and a history of consistent dividend growth, Johnson & Johnson stock is attractive to conservative investors seeking stable and income-generating returns. Add JNJ stock to your watchlist on Bulios and stay informed about the latest news and innovations from this established company.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Joaquin Duato

Employees

141,700

Headquarters

New Brunswick

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.